I totally agree with you about the potential for this company. And as always have much respect for your medical opinion on the science. However, science isn’t the only thing that matters at this point unfortunately.
Management has made such horrible decisions that we are left here running out of money at $.52 instead of $.80 because management made a boneheaded decision to announce a very risky RS that they weren’t even eligible to do in the first place and effectively killing the run up from PE. This is following the boneheaded decision to raise $10mm one trading day before announcing strong PE and effectively damping the only momentum we’ve had in a year before it even started.
Now we stand needing $35mm to get through 2018 and instead of raising at $1 or more we will be raising it at $.5-.6. Please tell me you at least understand these were unnecessary mistakes and it’s costing every investor time and money.
If I were a suitor and familiar with the missteps of the last 2 years I would be suspicious about what other horrible decisions have been made behind closed doors and what skeletons are in the closet.
There is definitely something wrong going on as Dr. P said in his email that they were able to over come obstacles with the FDA that the Prior company didn’t think was possible. What those obstacles are I don’t know but it seems like that are still haunting us. And managements boneheaded mistakes have just compounded.
News 
Market Data 
Discover 
